James P. Maloney - 16 Mar 2023 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chief Financial Officer
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
16 Mar 2023
Net transactions value
-$20,555
Form type
4
Filing time
01 May 2023, 08:48:04 UTC
Previous filing
22 Jul 2022
Next filing
24 Jul 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Tax liability $12,849 -123 -4.2% $104.46 2,821 16 Mar 2023 Direct
transaction MED Common Stock Tax liability $7,706 -75 -2.7% $102.75 2,746 17 Mar 2023 Direct
transaction MED Common Stock Award $0 +4,574 +167% $0.000000 7,320 17 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.